Trusted Resource for Clinical Trials, Protocols & Progress
Archiving and Confidentiality Obligations of ECs – Good Clinical Practice (GCP) and Compliance “Record Keeping and Privacy Duties of ECs” Introduction Archiving and confidentiality obligations are critical aspects of the responsibilities of Ethics Committees (ECs) in clinical studies. As a part of their duties, ECs are required to maintain the confidentiality of sensitive information and…
Structure and Composition of Ethics Committees – Good Clinical Practice (GCP) and Compliance “Ethics Committees: Structure and Composition” Introduction Ethics committees play a pivotal role in the realm of clinical studies, ensuring that the rights, safety, and wellbeing of human subjects are prioritized. They review, approve, and monitor biomedical research to ensure ethical guidelines are…
Safety Reporting Obligations of Sponsors – Good Clinical Practice (GCP) and Compliance “Responsibilities of Sponsors in Safety Reporting” Introduction to Safety Reporting Obligations of Sponsors In the world of clinical trials and research, safety reporting is a critical aspect that ensures the well-being of the participants and the integrity of the trial. Sponsors, typically pharmaceutical…
Read More “Safety Reporting Obligations of Sponsors – Good Clinical Practice (GCP) and Compliance” »
GCP Oversight of Vendors and CROs – Good Clinical Practice (GCP) and Compliance “Monitoring of Vendors and CROs by GCP” Introduction to GCP Oversight Good Clinical Practice (GCP) is a set of universally accepted ethical and scientific quality standards for the design, conduct, recording, and reporting of clinical trials involving human subjects. Compliance with these…
Read More “GCP Oversight of Vendors and CROs – Good Clinical Practice (GCP) and Compliance” »
Comparative Overview of Single vs Double Blinding – Clinical Trial Design and Protocol Development “Comparing Single and Double Blinding: An Overview” Comparative Overview of Single vs Double Blinding in Clinical Studies In the arena of clinical research, blinding is a critical practice that minimises bias and enhances the validity of data obtained. It’s a strategy…
Understanding the Levels of Blinding in Clinical Trials – Clinical Trial Design and Protocol Development “Comprehending the Different Stages of Blinding in Clinical Research” Introduction to Blinding in Clinical Trials In the realm of Clinical Studies, the concept of ‘blinding’ plays a critical role in maintaining the impartiality and accuracy of the trials. Blinding in…
Ethics of Open-Label Drug Access – Clinical Trial Design and Protocol Development “The Morality of Access to Unblinded Medication” Introduction The ethical implications of open-label drug access are complex and multifaceted. They traverse the fields of patient rights, scientific transparency, and the moral duty of pharmaceutical companies. Open-label drug access refers to the practice of…
Read More “Ethics of Open-Label Drug Access – Clinical Trial Design and Protocol Development” »
Examples of Open-Label Extensions Post-RCTs – Clinical Trial Design and Protocol Development ‘Samples of Post-RCT Open-Label Extension Studies’ Introduction to Open-Label Extensions Post-RCTs Open-label extensions are a valuable tool used in clinical research, particularly following Randomised Controlled Trials (RCTs). These extensions are designed to provide extended safety information, monitor long-term side effects, and assess the…
Regulatory Scrutiny of Open-Label Methodologies – Clinical Trial Design and Protocol Development “Examining the Regulatory Oversight of Open-Label Approaches” Understanding Open-Label Methodologies in Clinical Trials Open-label methodologies are an essential part of clinical trials, where both the investigators and the participants know the treatment each participant is receiving. Unlike double-blind studies, open-label methodologies do not…
Benefits and Risks of Transparency in Open-Label Studies – Clinical Trial Design and Protocol Development ‘Pros and Cons of Transparency in Open-Label Research’ Introduction Open-label studies are a type of clinical research where both the researcher and the participant are aware of the treatment or intervention being administered. This form of study stands in contrast…
